TY - JOUR
T1 - CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026
AU - The Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT)
AU - Ozaki, Yukio
AU - Tobe, Akihiro
AU - Onuma, Yoshinobu
AU - Miyashita, Kotaro
AU - Kobayashi, Yoshio
AU - Amano, Tetsuya
AU - Yamaji, Kyohei
AU - Ishii, Hideki
AU - Muramatsu, Takashi
AU - Ismail, Tevfik F.
AU - Kohsaka, Shun
AU - Nakagawa, Yoshihisa
AU - Morino, Yoshihiro
AU - Uemura, Shiro
AU - Tsujita, Kenichi
AU - Shinke, Toshiro
AU - Ako, Junya
AU - Yajima, Junji
AU - Maekawa, Yuichiro
AU - Shite, Junya
AU - Igarashi, Yasumi
AU - Shiode, Nobuo
AU - Okamura, Atsunori
AU - Ogawa, Takayuki
AU - Yamaguchi, Junichi
AU - Tamura, Toshihiro
AU - Tsuji, Takafumi
AU - Hayashida, Kentaro
AU - Sugano, Teruyasu
AU - Okura, Hiroyuki
AU - Okayama, Hideki
AU - Kawaguchi, Katsuhiro
AU - Zen, Kan
AU - Takahashi, Saeko
AU - Nakazato, Kazuhiko
AU - Suematsu, Nobuhiro
AU - Hironaga, Kiyoshi
AU - Matoba, Tetsuya
AU - Iida, Osamu
AU - Ishihara, Masaharu
AU - Ohta, Masaya
AU - Harada, Masahide
AU - Ozaki, Reina
AU - Izawa, Hideo
AU - Murohara, Toyoaki
AU - Ueno, Takafumi
AU - Nakamura, Masato
AU - Ikari, Yuji
AU - Serruys, Patrick W.
AU - Kozuma, Ken
N1 - Publisher Copyright:
© The Author(s) 2026.
PY - 2026/4
Y1 - 2026/4
N2 - Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022 (Ozaki et al. in Cardiovasc Interv Ther 33:178–203, 2018), (Ozaki et al. in Cardiovasc Interv Ther 37:1–34, 2022). Following the publication of the 2023 European Society of Cardiology (ESC) Guidelines for the management of acute coronary syndromes, the CVIT Task Force released another revised version in 2024 (Ozaki et al. in Cardiovasc Interv Ther 39:335–375, 2024). In light of new clinical evidence and technological advances that have emerged since then, the Task Force now proposes an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2026 version.
AB - Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022 (Ozaki et al. in Cardiovasc Interv Ther 33:178–203, 2018), (Ozaki et al. in Cardiovasc Interv Ther 37:1–34, 2022). Following the publication of the 2023 European Society of Cardiology (ESC) Guidelines for the management of acute coronary syndromes, the CVIT Task Force released another revised version in 2024 (Ozaki et al. in Cardiovasc Interv Ther 39:335–375, 2024). In light of new clinical evidence and technological advances that have emerged since then, the Task Force now proposes an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2026 version.
KW - Acute coronary syndrome (ACS)
KW - Non-ST-Segment elevation acute coronary syndrome (NSTE-ACS)
KW - Non-ST-Segment elevation acute myocardial infarction (NSTEMI)
KW - Percutaneous coronary intervention (PCI)
KW - ST-Segment elevation acute myocardial infarction (STEMI)
UR - https://www.scopus.com/pages/publications/105031945324
UR - https://www.scopus.com/pages/publications/105031945324#tab=citedBy
U2 - 10.1007/s12928-025-01229-z
DO - 10.1007/s12928-025-01229-z
M3 - Review article
C2 - 41749019
AN - SCOPUS:105031945324
SN - 1868-4300
VL - 41
SP - 209
EP - 255
JO - Cardiovascular Intervention and Therapeutics
JF - Cardiovascular Intervention and Therapeutics
IS - 2
ER -